ABOS
ABOS
US00509G2093
Acumen Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
154.76M EUR
193.08M EUR
170.46M EUR
127.81M EUR
Enterprise Value
73.32M EUR
165.28M EUR
149.82M EUR
105.14M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-1.49x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.7x
3.37x
1.95x
1.81x
EV/Revenue
--
--
--
--
EV/EBITDA
-0.7x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-36.51%
-47.54%
-61.92%
-63.71%
ende